{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:46:16Z","timestamp":1793033176930,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.trim.2023.101953","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T13:00:56Z","timestamp":1699102856000},"page":"101953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Therapeutic strategies against BK polyomavirus infection in kidney transplant recipients: Systematic review and meta-analysis"],"prefix":"10.1016","volume":"81","author":[{"given":"Cuiyu","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renfei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2023.101953_bb0005","article-title":"Predictive factors for BK polyomavirus infection in solid organ transplant recipients","volume":"7","author":"Gately","year":"2022","journal-title":"Cochrane Database Syst."},{"issue":"3","key":"10.1016\/j.trim.2023.101953_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/v13030487","article-title":"BK polyomavirus nephropathy in kidney transplantation: balancing rejection and infection","volume":"13","author":"Shen","year":"2021","journal-title":"Viruses."},{"issue":"6","key":"10.1016\/j.trim.2023.101953_bb0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5500\/wjt.v7.i6.329","article-title":"Polyoma virus nephropathy in kidney transplantation","volume":"7","author":"Scadden","year":"2017","journal-title":"World J. Transplant."},{"issue":"8","key":"10.1016\/j.trim.2023.101953_bb0020","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3390\/v14081616","article-title":"BK virus nephropathy in kidney transplantation: a state-of-the-art review","volume":"14","author":"Kant","year":"2022","journal-title":"Viruses."},{"issue":"S3","key":"10.1016\/j.trim.2023.101953_bb0025","first-page":"427","article-title":"Coexistence of BKPyV lytic infection and viral integration in the development of BKPyV diseases after renal transplantation","volume":"21","author":"Yan","year":"2021","journal-title":"Am. J. Transplant."},{"issue":"35","key":"10.1016\/j.trim.2023.101953_bb0030","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1038\/s41388-020-01398-6","article-title":"Viral integration in BK polyomavirus-associated urothelial carcinoma in renal transplant recipients: multistage carcinogenesis revealed by next-generation virome capture sequencing","volume":"39","author":"Wang","year":"2020","journal-title":"Oncogene."},{"issue":"3","key":"10.1016\/j.trim.2023.101953_bb0035","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2008.02519.x","article-title":"Identifying specific causes of kidney allograft loss","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.trim.2023.101953_bb0040","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3390\/genes13071290","article-title":"BK virus infection and BK-virus-associated nephropathy in renal transplant recipients","volume":"13","author":"Borriello","year":"2022","journal-title":"Genes (Basel)"},{"issue":"9","key":"10.1016\/j.trim.2023.101953_bb0045","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13528","article-title":"BK polyomavirus in solid organ transplantation-guidelines from the american society of transplantation infectious diseases community of practice","volume":"33","author":"Hirsch","year":"2019","journal-title":"Clin. Transpl."},{"issue":"6","key":"10.1016\/j.trim.2023.101953_bb0050","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2215\/CJN.12531211","article-title":"Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection","volume":"7","author":"Krisl","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol. Cjasn."},{"issue":"7","key":"10.1016\/j.trim.2023.101953_bb0055","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/TP.0b013e31828423cd","article-title":"Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis","volume":"95","author":"Knight","year":"2013","journal-title":"Transplantation."},{"issue":"3","key":"10.1016\/j.trim.2023.101953_bb0060","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2215\/CJN.04230413","article-title":"Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial","volume":"9","author":"Lee","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol. Cjasn."},{"issue":"2","key":"10.1016\/j.trim.2023.101953_bb0065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s40620-020-00777-2","article-title":"Everolimus for BKV nephropathy in kidney transplant recipients: a prospective, controlled study","volume":"34","author":"Bussalino","year":"2021","journal-title":"J. Nephrol."},{"issue":"8","key":"10.1016\/j.trim.2023.101953_bb0070","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/tri.13882","article-title":"Intravenous immunoglobulins do not prove beneficial to reduce alloimmunity among kidney transplant recipients with BKV-associated nephropathy","volume":"34","author":"Naef","year":"2021","journal-title":"Transpl. Int."},{"issue":"1","key":"10.1016\/j.trim.2023.101953_bb0075","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1186\/s12879-023-08577-2","article-title":"Fatal BK polyomavirus-associated pneumonia: report of two cases with literature review","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.trim.2023.101953_bb0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.6002\/ect.MESOT2018.O17","article-title":"Screening for BK viremia\/viruria and the impact of management of BK virus nephropathy in renal transplant recipients","volume":"17","author":"Zakaria","year":"2019","journal-title":"Exp. Clin. Transplant."},{"issue":"1","key":"10.1016\/j.trim.2023.101953_bb0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cmi.2018.07.027","article-title":"BK polyomavirus in the urine for follow-up of kidney transplant recipients","volume":"25","author":"Brochot","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"issue":"35","key":"10.1016\/j.trim.2023.101953_bb0090","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1038\/s41388-020-01398-6","article-title":"Viral integration in BK polyomavirus-associated urothelial carcinoma in renal transplant recipients: multistage carcinogenesis revealed by next-generation virome capture sequencing","volume":"39","author":"Wang","year":"2020","journal-title":"Oncogene."},{"issue":"1","key":"10.1016\/j.trim.2023.101953_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control. Clin. Trials"},{"issue":"9","key":"10.1016\/j.trim.2023.101953_bb0100","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J. Surg."},{"key":"10.1016\/j.trim.2023.101953_bb0105","series-title":"Joanna Briggs Institute Reviewer\u2019s Manual","author":"Moola","year":"2017"},{"key":"10.1016\/j.trim.2023.101953_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Bmj (Clinical Research Ed.)."},{"issue":"8","key":"10.1016\/j.trim.2023.101953_bb0115","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.transproceed.2017.06.030","article-title":"Mycophenolate Mofetil withdrawal with conversion to Everolimus to treat BK virus infection in kidney transplant recipients","volume":"49","author":"Wojciechowski","year":"2017","journal-title":"Transplant. Proc."},{"issue":"1","key":"10.1016\/j.trim.2023.101953_bb0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.transproceed.2014.11.008","article-title":"Everolimus-based immunosuppression therapy for BK virus nephropathy","volume":"47","author":"Polanco","year":"2015","journal-title":"Transplant. Proc."},{"issue":"6","key":"10.1016\/j.trim.2023.101953_bb0125","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/tid.12313","article-title":"Observations on the use of cidofovir for BK virus infection in renal transplantation","volume":"16","author":"Kuten","year":"2014","journal-title":"Transplant Infect. Dis."},{"issue":"2","key":"10.1016\/j.trim.2023.101953_bb0130","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/jac\/dkn495","article-title":"A single-Centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients","volume":"63","author":"Kuypers","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.trim.2023.101953_bb0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1399-3046.2005.00391.x","article-title":"Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy","volume":"10","author":"Araya","year":"2006","journal-title":"Pediatr. Transplant."},{"issue":"4","key":"10.1016\/j.trim.2023.101953_bb0140","first-page":"178","article-title":"Leflunomide for BKvirus: report of seven kidney-transplanted children","volume":"9","author":"Launay","year":"2018","journal-title":"Int J Organ Transplant Med."},{"issue":"1","key":"10.1016\/j.trim.2023.101953_bb0145","doi-asserted-by":"crossref","first-page":"34","DOI":"10.15171\/jnp.2016.06","article-title":"Evaluation of leflunomide for the treatment of BK viremia and biopsy proven BK nephropathy; a single center experience","volume":"5","author":"Nesselhauf","year":"2016","journal-title":"J. Nephropathol."},{"issue":"3","key":"10.1016\/j.trim.2023.101953_bb0150","doi-asserted-by":"crossref","first-page":"E230","DOI":"10.1111\/ctr.12110","article-title":"Contrasting patterns of viral load response in transplant recipients with BK polyomavirus DNAemia on leflunomide therapy","volume":"27","author":"Cuellar-Rodriguez","year":"2013","journal-title":"Clin. Transpl."},{"issue":"6","key":"10.1016\/j.trim.2023.101953_bb0155","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.transproceed.2009.06.099","article-title":"Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection","volume":"41","author":"Teschner","year":"2009","journal-title":"Transplant. Proc."},{"issue":"3","key":"10.1016\/j.trim.2023.101953_bb0160","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2215\/CJN.03930907","article-title":"Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients","volume":"3","author":"Leca","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol. Cjasn."},{"issue":"11","key":"10.1016\/j.trim.2023.101953_bb0165","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1432-2277.2007.00523.x","article-title":"Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation","volume":"20","author":"Faguer","year":"2007","journal-title":"Transpl. Int."},{"issue":"11","key":"10.1016\/j.trim.2023.101953_bb0170","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJM200503173521125","article-title":"Leflunomide for polyomavirus type BK nephropathy","volume":"352","author":"Williams","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2023.101953_bb0175","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2147\/TCRM.S273388","article-title":"Clinical efficacy of intravenous immunoglobulin for BK polyomavirus-associated nephropathy after living kidney transplantation","volume":"16","author":"Matsumura","year":"2020","journal-title":"Ther. Clin. Risk Manag."},{"issue":"4","key":"10.1016\/j.trim.2023.101953_bb0180","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13300","article-title":"Effects of intravenous immunoglobulin therapy and fc gamma receptor polymorphisms on BK virus nephropathy in kidney transplant recipients","volume":"22","author":"Moon","year":"2020","journal-title":"Transplant Infect. Dis."},{"issue":"4","key":"10.1016\/j.trim.2023.101953_bb0185","article-title":"Clearance of BK virus nephropathy by combination antiviral therapy with intravenous immunoglobulin","volume":"3","author":"Kable","year":"2017","journal-title":"Transplant. Direct"},{"issue":"6","key":"10.1016\/j.trim.2023.101953_bb0190","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.transproceed.2020.01.158","article-title":"Clinical characteristic and outcomes of BK virus infection in kidney transplant recipients managed using a systematic surveillance and treatment strategy","volume":"52","author":"Lee","year":"2020","journal-title":"Transplant. Proc."},{"issue":"5","key":"10.1016\/j.trim.2023.101953_bb0195","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13460","article-title":"BK viremia and nephropathy in pediatric renal transplant recipients","volume":"23","author":"Hamasaki","year":"2019","journal-title":"Pediatr. Transplant."},{"issue":"13","key":"10.1016\/j.trim.2023.101953_bb0200","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5414\/CNP88FX24","article-title":"Outcome of polyomavirus nephropathy in renal transplant patients: a single-center experience","volume":"88","author":"Kojc","year":"2017","journal-title":"Clin. Nephrol."},{"issue":"1","key":"10.1016\/j.trim.2023.101953_bb0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.diagmicrobio.2014.09.024","article-title":"Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis","volume":"81","author":"Huang","year":"2015","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.trim.2023.101953_bb0210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000313888","article-title":"Surveillance and modification of immunosuppression minimizes BK virus nephropathy","volume":"32","author":"Bennett","year":"2010","journal-title":"Am. J. Nephrol."},{"issue":"4","key":"10.1016\/j.trim.2023.101953_bb0215","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.transproceed.2009.03.091","article-title":"Impact of preemptive reduction of immunosuppression with serial monitoring for BK virus replication in renal transplant recipients undergoing short-term evaluation","volume":"41","author":"De Paolis","year":"2009","journal-title":"Transplant. Proc."},{"issue":"8","key":"10.1016\/j.trim.2023.101953_bb0220","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/TP.0b013e31816a33d4","article-title":"Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study","volume":"85","author":"Alm\u00e9ras","year":"2008","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2023.101953_bb0225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ebiom.2018.07.017","article-title":"BKV, CMV, and EBV interactions and their effect on graft function one year post-renal transplantation: results from a large multi-Centre study","volume":"34","author":"Blazquez-Navarro","year":"2018","journal-title":"Ebiomedicine."},{"issue":"2","key":"10.1016\/j.trim.2023.101953_bb0230","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1600-6143.2009.02952.x","article-title":"BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results","volume":"10","author":"Hardinger","year":"2010","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.trim.2023.101953_bb0235","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1016\/j.transproceed.2005.08.018","article-title":"BK virus nephropathy in renal transplant recipients in Kuwait: a preliminary report","volume":"37","author":"Nampoory","year":"2005","journal-title":"Transplant. Proc."},{"issue":"6","key":"10.1016\/j.trim.2023.101953_bb0240","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1399-3062.2011.00649.x","article-title":"Mammalian target of rapamycin signal inhibitors could play a role in the treatment of BK polyomavirus nephritis in renal allograft recipients","volume":"13","author":"S\u00e1nchez Fructuoso","year":"2011","journal-title":"Transpl. Infect. Dis."},{"issue":"1","key":"10.1016\/j.trim.2023.101953_bb0245","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.tp.0000181096.14257.c2","article-title":"Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients","volume":"81","author":"Sener","year":"2006","journal-title":"Transplantation."},{"issue":"9","key":"10.1016\/j.trim.2023.101953_bb0250","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1016\/j.transproceed.2008.09.002","article-title":"Treatment of BK virus-associated nephropathy with Cidofovir in renal transplantation","volume":"40","author":"Cabello","year":"2008","journal-title":"Transplant. Proc."},{"issue":"2","key":"10.1016\/j.trim.2023.101953_bb0255","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13228","article-title":"Low-dose cidofovir and conversion to mTOR-based immunosuppression in polyomavirus-associated nephropathy","volume":"22","author":"M\u00fchlbacher","year":"2020","journal-title":"Transpl. Infect. Dis."},{"issue":"2","key":"10.1016\/j.trim.2023.101953_bb0260","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.transproceed.2015.01.012","article-title":"Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients","volume":"47","author":"Vu","year":"2015","journal-title":"Transplant. Proc."},{"issue":"2","key":"10.1016\/j.trim.2023.101953_bb0265","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13058","article-title":"Clinical utility of leflunomide for BK polyomavirus associated nephropathy in kidney transplant recipients: a multicenter retrospective study","volume":"21","author":"Keller","year":"2019","journal-title":"Transpl. Infect. Dis."},{"issue":"8","key":"10.1016\/j.trim.2023.101953_bb0270","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1111\/j.1600-6143.2005.00980.x","article-title":"Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients","volume":"5","author":"Kuypers","year":"2005","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.trim.2023.101953_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2044","article-title":"BK virus: current understanding of pathogenicity and clinical disease in transplantation","volume":"29","author":"Chong","year":"2019","journal-title":"Rev. Med. Virol."},{"issue":"6","key":"10.1016\/j.trim.2023.101953_bb0280","first-page":"S592","article-title":"BK polyomavirus integration increases both host and viral oncogene expression","volume":"23","author":"Wang","year":"2023","journal-title":"Am. J. Transplant."},{"issue":"11","key":"10.1016\/j.trim.2023.101953_bb0285","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.ajt.2023.07.014","article-title":"Dynamic viral integration patterns actively participate in the progression of BK polyomavirus-associated diseases after renal transplantation","volume":"23","author":"Wang","year":"2023","journal-title":"Am. J. Transplant."},{"issue":"S3","key":"10.1016\/j.trim.2023.101953_bb0290","first-page":"445","article-title":"Concordance of POLQ and PARP-1 expression and MMEJ type viral integration in the progression of BKPyV-associated diseases","volume":"22","author":"Wang","year":"2022","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.trim.2023.101953_bb0295","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/ajt.13083","article-title":"Commercially available immunoglobulins contain virus neutralizing antibodies against all major genotypes of polyomavirus BK","volume":"15","author":"Randhawa","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.trim.2023.101953_bb0300","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/ajt.16233","article-title":"Intravenous immunoglobulin as a preventive strategy against BK virus viremia and BKV-associated nephropathy in kidney transplant recipients\u2014results from a proof-of-concept study","volume":"21","author":"Benotmane","year":"2021","journal-title":"Am. J. Transplant."},{"issue":"11","key":"10.1016\/j.trim.2023.101953_bb0305","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14824","article-title":"Topical cidofovir-related acute kidney injury in a kidney transplant recipient","volume":"36","author":"Velioglu","year":"2022","journal-title":"Clin. Transpl."},{"issue":"6","key":"10.1016\/j.trim.2023.101953_bb0310","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13433","article-title":"Fluoroquinolones for BK viral complication after transplantation: Meta-analysis","volume":"22","author":"Ito","year":"2020","journal-title":"Transplant Infect. Dis."},{"issue":"8","key":"10.1016\/j.trim.2023.101953_bb0315","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/TP.0b013e31826690c6","article-title":"Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study","volume":"94","author":"Sood","year":"2012","journal-title":"Transplantation."},{"issue":"22","key":"10.1016\/j.trim.2023.101953_bb0320","first-page":"5745","article-title":"Virus-specific T-cell therapy to treat BK polyomavirus infection in bone marrow and solid organ transplant recipients","volume":"4","author":"Nelson","year":"2020","journal-title":"Blood Adv."},{"issue":"S3","key":"10.1016\/j.trim.2023.101953_bb0325","first-page":"595","article-title":"A randomized phase 2 study of MAU868 vs placebo to treat BK viremia in kidney transplant recipients","volume":"22","author":"Jordan","year":"2022","journal-title":"Am. J. Transplant."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327423001703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327423001703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:06:15Z","timestamp":1760810775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327423001703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":65,"alternative-id":["S0966327423001703"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2023.101953","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic strategies against BK polyomavirus infection in kidney transplant recipients: Systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2023.101953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101953"}}